Developer of an artificial intelligence based data aggregation and technology platform designed to bolster the cannabis industry to higher medical standards. The company's platform aggregates and correlates HIPAA-compliant medical data and gathers insightful data on cannabis from seed to consumption, enabling doctors to personalize cannabis in order to better predict treatment outcomes.
Generating Revenue
In IPO Registration
Accelerator/Incubator Backed
The company reached a definitive agreement to acquire Express Capital through a reverse merger, resulting in the combined entity trading on the CSE on September 26, 2018. Previously, the company joined The Blinc Group on November 15, 2017.
Add a review